487PPatient selection for targeting integrin with abituzumab in patients with metastatic colorectal cancer (mCRC): A retrospective analysis of the randomized phase I/II Poseidon study. (23rd October 2018) - Laeufle, R; Arnold, D; Kopetz, S; Straub, J; Bruns, R; Massimini, G; Debenedetto, R; Linke, R; Elez Fernandez, E; Tabernero, J